fda warning letters compounded semaglutide november 2025 Semaglutide: The Drug of Today and a Steppingstone to Tomorrow September 8, 2025: FDA launches

High-resolution crystal structure of the snake venom metalloproteinase BaP1 complexed with a peptidomimetic: Insight into inhibitor binding

But the authors appropriately noted limitations: the retrospective design, small sample size, and the fact that most patients were already in remission when starting therapy

Novo Nordisk announced its rebranded oral semaglutide pill, Rybelsus, will soon be available as the Ozempic pill following a formulation change

These moves create more developments to monitor across different therapeutic categories, not only obesity drugs

Pharmaceutical therapy, where indicated, must not be projected in a manner that undermines public health initiatives promoting diet control, physical activity, and preventive healthcare measures, the DCGI advisory stated